Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation

American Journal of Cardiology

Volumn 106, Issue 10, 2010, Pages 1487-1491

  Yuan, Jiansong ^a   Qiao, Shubin ^a   Zhang, Yan ^a   You, Shijie ^a   Duan, Fujian ^a   Hu, Fenghuan ^a   Yang, Weixian ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ABLATION THERAPY; ADULT; ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS VENTRICULAR SEPTAL ABLATION; PRIORITY JOURNAL;

ABLATION TECHNIQUES; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 78149471437     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.07.017     Document Type: Article

References (14)

1. J. Mogelvang, K. Lindvig, L. Sondergaard, K. Saunamaki, and O. Henriksen Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI Clin Physiol 13 1993 587 597
2. S.G. Myerson, N.G. Bellenger, and D.J. Pennell Assessment of left ventricular mass by cardiovascular magnetic resonance Hypertension 39 2002 750 755
3. W.G. van Dockum, F.J. ten Cate, J.M. ten Berg, A.M. Beek, J.W. Twisk, J. Vos, M.B. Hofman, C.A. Visser, and A.C. van Rossum Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging J Am Coll Cardiol 43 2004 27 34
4. Butz T, Horstkotte D, Koerfer J, Langer C, Seggewiss H, Faber L. Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Int J Cardiol Epub 2009 Jan 24.
5. L. Faber, D. Welge, D. Fassbender, H.K. Schmidt, D. Horstkotte, and H. Seggewiss One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response Clin Res Cardiol 96 2007 864 873
6. L. Faber, H. Seggewiss, D. Welge, D. Fassbender, H.K. Schmidt, U. Gleichmann, and D. Horstkotte Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience Eur J Echocardiogr 5 2004 347 355
7. W.G. van Dockum, A.M. Beek, F.J. ten Cate, J.M. ten Berg, O. Bondarenko, M.J.W. Gotte, J.W.R. Twisk, M.B.M. Hofman, C.A. Visser, and A.C. van Rossum Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy Circulation 111 2005 2503 2508
8. G.P. McCann, W.G. van Dockum, A.M. Beek, R. Nijveldt, F.J. ten Cate, J.M. ten Berg, and A.C. van Rossum Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy Am J Cardiol 99 2007 563 567
9. D.R. Talreja, R.A. Nishimura, W.D. Edwards, U.S. Valeti, S.R. Ommen, A.J. Tajik, J.A. Dearani, H.V. Schaff, and D.R. Holmes Jr Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue J Am Coll Cardiol 44 2004 2329 2332
10. J.X. Qin, T. Shiota, H.M. Lever, C.R. Asher, Z.B. Popovi, N.L. Greenberg, D.A. Agler, J.K. Drinko, N.G. Smedira, E.M. Tuzcu, B.W. Lytle, and J.D. Thomas Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions Am J Cardiol 93 2004 171 175
11. L. Faber, A. Meissner, P. Ziemssen, and H. Seggewiss Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients Heart 83 2000 326 331
12. W. Mazur, S.F. Nagueh, N.M. Lakkis, K.J. Middleton, D. Killip, R. Roberts, and W.H. Spencer III Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Circulation 103 2001 1492 1496
13. H. Kuhn, H. Seggewiss, F.H. Gietzen, P. Boekstegers, L. Neuhaus, and L. Seipel Catheter-based therapy for hypertrophic obstructive cardiomyopathy: first in-hospital outcome analysis of the German TASH Registry Z Kardiol 93 2004 23 31
14. S.F. Nagueh, S.R. Ommen, N.M. Lakkis, D. Killip, W.A. Zoghbi, H.V. Schaff, G.K. Danielson, M.A. Quiones, A.J. Tajik, and W.H. Spencer Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 38 2001 1701 1706